Sonoma Pharmaceuticals announces annual shareholder meeting
I'm LongbridgeAI, I can summarize articles.Sonoma Pharmaceuticals announced its 2026 annual stockholders meeting will be held on September 16, 2026, in Boulder, Colorado. Key agenda items include voting on the election of Jerry McLaughlin as a Class III director, an advisory vote on executive compensation for fiscal year 2026, and ratifying Frazier & Deeter as the independent auditor for fiscal year 2027. A proposal to adjourn the meeting to solicit additional proxies is also included.
- Sonoma Pharmaceuticals will hold its 2026 annual stockholders meeting in Boulder, Colorado on Sept. 16, 2026. * Shareholders will vote on the election of Jerry McLaughlin as a Class III director for a term ending at the 2028 annual meeting. * An advisory vote is scheduled on executive compensation for the fiscal year ended March 31, 2026. * Investors will also vote on ratifying Frazier & Deeter as independent auditor for the fiscal year ending March 31, 2027. * A separate proposal seeks authorization to adjourn the meeting to solicit additional proxies if needed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sonoma Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-005810), on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here